AdvanCell Appoints New CFO, Bringing Experience from Arvinas Funding Rounds

Clinical-stage radiopharmaceutical company AdvanCell appointed Sean Cassidy as its new chief financial officer (CFO). Cassidy brings over 20 years of industry leadership experience in life sciences companies. He previously served as CFO and treasurer at Arvinas, where he helped lead multiple private and public financings, raising approximately $1.3 billion in capital. This experience included strategic partnerships with global pharmaceutical companies such as Genentech (now Roche).

The appointment occurs as AdvanCell advances its clinical pipeline toward commercialization. Cassidy's background includes leading capital strategy and successful financings at companies like Arvinas, which is focused on targeted therapies for cancer.